Fact sheets covering Provider payment, reimbursement, claims submissions and prior authorization have been recently published on the NC Medicaid website.
Update includes provider verification, billing requirement modifications; Tailored Plan implementation, upcoming key milestones, playbook updates and more.
Effective with date of service Jan. 27, 2023, the Medicaid and NC Health Choice programs covers ublituximab-xiiy injection, for intravenous use (Briumvi)
Effective with date of service Jan. 20, 2023, the Medicaid and NC Health Choice programs cover fecal microbiota, live - jslm suspension, for rectal use (Rebyota).